Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
Resistente 'E. coli' overgedragen door fecestransplantatie
nov 2019 | Antibioticaresistentie, Bacteriële infecties, Transplantatie